对比FDA和CFDA批准的抗癌药物列表
更新时间:2023-10-06 15:24:01 阅读量: 综合文库 文档下载
?
对比FDA和CFDA批准的抗癌药物列表。
?
发现事实。下面的都是FDA批准的靶点药,而有中文名称的是CFDA允许在国内销售的。
可以说,国内病人基本享受不到自从05年以来的绝大多数抗癌研究成果。为父亲大人学习相关知识。
AgentTarget(s)FDA-approved indication(s)CFDA approved
Ado-trastuzumab emtansine
HER2 (ERBB2/neu)
(Kadcyla)
EGFR (HER1/ERBB1), HER2
Afatinib (Gilotrif)
(ERBB2/neu)
Aldesleukin (Proleukin)
Alemtuzumab (Campath) Axitinib (Inlyta) Belimumab (Benlysta) Belinostat (Beleodaq) Bevacizumab (Avastin)
Bortezomib (Velcade) [1] |
2014-12-30 11:28jastee
CD52
KIT, PDGFRβ, VEGFR1/2/3 BAFF HDAC VEGF ligand Proteasome
21 substitution (L858R) mutations) Renal cell carcinoma Melanoma
B-cell chronic lymphocytic leukemia Renal cell carcinoma Lupus erythematosus Peripheral T-cell lymphoma Cervical cancer
注射液
Colorectal cancer Fallopian tube cancer Glioblastoma
Non-small cell lung cancer Ovarian cancer Peritoneal cancer Renal cell carcinoma Multiple myeloma
佐米 注射用硼替 贝伐珠单抗
Non-small cell lung cancer (with EGFR exon 19 deletions or exon
Breast cancer (HER2+)
Bosutinib (Bosulif) Brentuximab vedotin
ABL CD30
Mantle cell lymphoma
Chronic myelogenous leukemia (Philadelphia chromosome positive) Hodgkin lymphoma
Anaplastic large cell lymphoma Medullary thyroid cancer
(Adcetris)
Cabozantinib (Cometriq)
VEGFR2
Canakinumab (Ilaris)
Carfilzomib (Kyprolis)
IL-1β Proteasome
Juvenile idiopathic arthritis
Cryopyrin-associated periodic syndromes Multiple myeloma
FLT3, KIT, MET, RET,
Ceritinib (Zykadia) Cetuximab (Erbitux)
Crizotinib (Xalkori) Dabrafenib (Tafinlar) Dasatinib (Sprycel)
Denosumab (Xgeva) Erlotinib (Tarceva)
Everolimus (Afinitor)
Gefitinib (Iressa) Ibritumomab tiuxetan
ALK
EGFR (HER1/ERBB1) ALK, MET BRAF ABL RANKL
EGFR (HER1/ERBB1) mTOR
Non-small cell lung cancer (with ALK fusion) Colorectal cancer (KRAS wild type)
西妥昔单抗注射液
Squamous cell cancer of the head and neck Non-small cell lung cancer (with ALK fusion) Melanoma (with BRAF V600 mutation)
Chronic myelogenous leukemia (Philadelphia chromosome positive) Acute lymphoblastic leukemia (Philadelphia chromosome positive) Giant cell tumor of the bone Non-small cell lung cancer
克唑替尼胶囊
达沙替尼片
盐酸厄洛替尼片
Pancreatic cancer
Pancreatic neuroendocrine tumor Renal cell carcinoma
Nonresectable subependymal giant cell astrocytoma associated with
依维莫司片
tuberous sclerosis
EGFR (HER1/ERBB1)
(limited approval)
CD20
(Zevalin)
Ibrutinib (Imbruvica) |
2014-12-30 11:29jastee
BTK
Mantle cell lymphoma
Non-Hodgkin's lymphoma
Breast cancer (HR+, HER2-)
Non-small cell lung cancer with known prior benefit from gefitinib
吉非替尼片
Idelalisib (Zydelig)
Imatinib (Gleevec)
Ipilimumab (Yervoy) Lapatinib (Tykerb)
PI3Kδ
KIT, PDGFR, ABL
Chronic lymphocytic leukemia Chronic lymphocytic leukemia
Follicular B-cell non-Hodgkin lymphoma Small lymphocytic lymphoma GI stromal tumor (KIT+) Dermatofibrosarcoma protuberans
Multiple hematologic malignancies including Philadelphia
chromosome-positive ALL and CML
CTLA-4
HER2 (ERBB2/neu), EGFR
Breast cancer (HER2+)
(HER1/ERBB1)
Chronic myelogenous leukemia (Philadelphia chromosome
Nilotinib (Tasigna) Obinutuzumab (Gazyva) Ofatumumab (Arzerra,
CD20
HuMax-CD20)
Panitumumab (Vectibix) Pazopanib (Votrient)
EGFR (HER1/ERBB1) VEGFR, PDGFR, KIT
Colorectal cancer (KRAS wild type) Renal cell carcinoma Melanoma
Breast cancer (HER2+)
Chronic lymphocytic leukemia
ABL
positive)
CD20
Chronic lymphocytic leukemia
囊 尼洛替尼胶
Melanoma
Pembrolizumab (Keytruda) PD-1 Pertuzumab (Perjeta)
HER2 (ERBB2/neu)
Ponatinib (Iclusig)
Ramucirumab (Cyramza) ABL, FGFR1-3, FLT3, VEGFR2 Chronic myelogenous leukemia VEGFR2
Acute lymphoblastic leukemia (Philadelphia chromosome positive) Gastric cancer or Gastroesophageal junction (GEJ) adenocarcinoma
Regorafenib (Stivarga)
Rituximab (Rituxan, Mabthera)
Romidepsin (Istodax)
Ruxolitinib (Jakafi) Siltuximab (Sylvant) Sipuleucel-T (Provenge) Sorafenib (Nexavar)
Temsirolimus (Torisel) Tocilizumab (Actemra)
Tofacitinib (Xeljanz) Tositumomab (Bexxar) Trametinib (Mekinist) Trastuzumab (Herceptin)
Vandetanib (Caprelsa)
Vemurafenib (Zelboraf) Vismodegib (Erivedge) Vorinostat (Zolinza) Ziv-aflibercept (Zaltrap)
KIT, PDGFRβ, RAF, RET,
VEGFR1/2/3 CD20
HDAC JAK1/2 IL-6
VEGFR, PDGFR, KIT, RAF mTOR IL-6R JAK3 CD20 MEK
HER2 (ERBB2/neu)
EGFR (HER1/ERBB1), RET,
VEGFR2
BRAF
PTCH, Smoothened HDAC
PIGF, VEGFA/B
Colorectal cancer
Gastrointestinal stromal tumors Non-Hodgkin’s lymphoma
Chronic lymphocytic leukemia Rheumatoid arthritis
Granulomatosis with polyangiitis Cutaneous T-cell lymphoma Peripheral T-cell lymphoma Myelofibrosis
Multicentric Castleman's disease Prostate cancer
Hepatocellular carcinoma
Renal cell carcinoma Thyroid carcinoma Renal cell carcinoma Rheumatoid arthritis
Juvenile idiopathic arthritis Rheumatoid arthritis Non-Hodgkin's lymphoma
Melanoma (with BRAF V600 mutation) Breast cancer (HER2+)
Gastric cancer (HER2+) Medullary thyroid cancer
Melanoma (with BRAF V600 mutation) Basal cell carcinoma Cutaneous T-cell lymphoma Colorectal cancer
.利妥昔单抗注射液
甲苯磺酸索拉非尼片
托珠单抗注射液
注射用曲妥珠单抗 (
正在阅读:
对比FDA和CFDA批准的抗癌药物列表10-06
关于学习贯彻《2018年全省纪检监察系统内部巡察工作情况通报》的报告10-04
餐饮业服务人员短缺的原因及对策07-24
Nagios监控系统部署04-05
综合实践活动心得体会12-02
盐城中国海盐博物馆展陈大纲10-27
浅谈Flash动画设计项目教学效果的提高05-15
- 多层物业服务方案
- (审判实务)习惯法与少数民族地区民间纠纷解决问题(孙 潋)
- 人教版新课标六年级下册语文全册教案
- 词语打卡
- photoshop实习报告
- 钢结构设计原理综合测试2
- 2014年期末练习题
- 高中数学中的逆向思维解题方法探讨
- 名师原创 全国通用2014-2015学年高二寒假作业 政治(一)Word版
- 北航《建筑结构检测鉴定与加固》在线作业三
- XX县卫生监督所工程建设项目可行性研究报告
- 小学四年级观察作文经典评语
- 浅谈110KV变电站电气一次设计-程泉焱(1)
- 安全员考试题库
- 国家电网公司变电运维管理规定(试行)
- 义务教育课程标准稿征求意见提纲
- 教学秘书面试技巧
- 钢结构工程施工组织设计
- 水利工程概论论文
- 09届九年级数学第四次模拟试卷
- 抗癌药物
- 批准
- 对比
- 列表
- CFDA
- FDA
- matlab第2章练习及答案
- 长沙水泵厂ZDGS280-95×5自平衡多级泵
- 常用心理评估量表手册整理
- RLE - CA03 - 灯泵YAG激光调Q综合实验 - 图文
- 儿科应急预案
- 滦县春玉米高产创建技术规范模式图
- 电子时钟单片机课程设计
- PEST分析模型(PEST Analysis)
- 浦东国际机场新建围界区域土方平整工程
- 酶切位点保护碱基表新
- 十六种标点符号的输入形式和一般用法
- 1994年全国初中数学联赛试题技巧归纳
- 北京大学软件与微电子学院2016年计算机技术硕士专业学位研究生招生简章
- 卢映川:全力提升城市七大品质
- 06级大学物理(下)A卷及答03
- 2009年普通高等学校招生全国统一考试(辽宁卷)数学(文史类)
- 洗灌封一体机验证方案
- 环保时装秀策划书
- (修改) IV级突发食品安全事故应急预案演练脚本分解 - 图文
- 霍尔效应测磁场实验报告